文献速递抗栓抗凝管理特殊人群用药

Geisinger 药物治疗疾病管理:人群健康管理实践

Medication therapy disease management: Geisinger's approach to population health management.
PubMed 文献 · Am J Health Syst Pharm · 2017-01-01

本文描述 Geisinger 医疗系统的药物治疗疾病管理(MTDM)项目中药师参与慢性病管理的人群健康举措。MTDM 项目始于1996年,药师经培训认证可管理超过16种疾病;在房颤患者中,药师管理华法林者年均急诊就诊和住院各减少18%、年度总医疗费用降低23%;在多发性硬化患者中,药师管理药学治疗者年均急诊就诊减少28%,但年度总医疗费用高21%。

要点

  • 药师经培训认证可管理超过16种慢性疾病,包括房颤和多发性硬化。
  • 房颤患者由药师管理华法林,年均急诊和住院各减少18%,总费用低23%。
  • 多发性硬化患者由药师管理药学治疗,年均急诊减少28%,但总费用高21%。

核心结论

  • Geisinger MTDM 项目从单药师抗凝门诊发展为覆盖不断增长人群的大型人群健康管理项目。
  • 药师融入临床照护框架的初期挑战通过展示 MTDM 对患者结局的积极影响而克服。

研究设计与样本

  • 描述 Geisinger Health System 门诊药学项目 MTDM 的人群健康举措。
  • MTDM 项目始于1996年,药师经培训认证可管理超过16种疾病。

主要发现

  • 15年期间,GHP 保险的房颤患者中,药师管理华法林者年均急诊就诊减少18%、住院减少18%、年度总医疗费用降低23%。
  • 2年期间,GHP 保险的多发性硬化患者中,药师管理药学治疗者年均急诊就诊减少28%,但年度总医疗费用高21%。

临床怎么用

  • 药师可经培训认证管理多种慢性疾病,包括房颤华法林抗凝和多发性硬化药学治疗。
  • 药师管理华法林抗凝可减少房颤患者急诊就诊、住院和总医疗费用。
  • 药师管理多发性硬化药学治疗可减少急诊就诊,但需关注总医疗费用可能升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pharmacists' involvement in a population health initiative focused on chronic disease management is described. SUMMARY: Geisinger Health System has cultivated a culture of innovation in population health management, as highlighted by its ambulatory care pharmacy program, the Medication Therapy Disease Management (MTDM) program. Initiated in 1996, the MTDM program leverages pharmacists' pharmacotherapy expertise to optimize care and improve outcomes. MTDM program pharmacists are trained and credentialed to manage over 16 conditions, including atrial fibrillation (AF) and multiple sclerosis (MS). Over a 15-year period, Geisinger Health Plan (GHP)-insured patients with AF whose warfarin therapy was managed by the MTDM program had, on average, 18% fewer emergency department (ED) visits and 18% fewer hospitalizations per year than GHP enrollees with AF who did not receive MTDM services, with 23% lower annual total care costs. Over a 2-year period, GHP-insured patients with MS whose pharmacotherapy was managed by pharmacists averaged 28% fewer annual ED visits than non-pharmacist-managed patients; however, the mean annual total care cost was 21% higher among MTDM clinic patients. CONCLUSION: The Geisinger MTDM program has evolved over 20 years from a single pharmacist-run anticoagulation clinic into a large program focused on managing the health of an ever-growing population. Initial challenges in integrating pharmacists into the Geisinger patient care framework as clinical experts were overcome by demonstrating the MTDM program's positive impact on patient outcomes.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Jones LK, Greskovic G, Grassi DM, et al. Medication therapy disease management: Geisinger's approach to population health management. Am J Health Syst Pharm. 2017. PMID: 28887344. doi:10.2146/ajhp161061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。